Evidence map›Paper›PMID 39065238›Full record

ReviewMicroorganisms2024

The Early Appearance of Asthma and Its Relationship with Gut Microbiota: A Narrative Review.

Clara Suárez-Martínez, Marina Santaella-Pascual, Genoveva Yagüe-Guirao, Luis García-Marcos, Gaspar Ros, Carmen Martínez-Graciá

Abstract readReview
In one paragraph

Review in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Gut eutrophication.Frontiers in microbiomes · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Clara Suárez-MartínezBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.ORCID 0000-0003-1802-4329
Marina Santaella-PascualBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Genoveva Yagüe-GuiraoBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Luis García-MarcosBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.ORCID 0000-0002-0925-3851
Gaspar RosBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.ORCID 0000-0002-8894-4481
Carmen Martínez-GraciáBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.ORCID 0000-0002-3195-825X

Funding

Agencia Estatal de Investigación PID2019-106693RB-100/AEI/10.13039/501100011033Instituto de Salud Carlos III CP14/0046Instituto de Salud Carlos III PI16/00422Ministerio de Ciencia, Innovación y Universidades PIE15/0051The Spanish Multidisciplinary Research Network for Allergic Diseases RD160006
6 · The paper itself

Abstract

Asthma is, worldwide, the most frequent non-communicable disease affecting both children and adults, with high morbidity and relatively low mortality, compared to other chronic diseases. In recent decades, the prevalence of asthma has increased in the pediatric population, and, in general, the risk of developing asthma and asthma-like symptoms is higher in children during the first years of life. The "gut-lung axis" concept explains how the gut microbiota influences lung immune function, acting both directly, by stimulating the innate immune system, and indirectly, through the metabolites it generates. Thus, the process of intestinal microbial colonization of the newborn is crucial for his/her future health, and the alterations that might generate dysbiosis during the first 100 days of life are most influential in promoting hypersensitivity diseases. That is why this period is termed the "critical window". This paper reviews the published evidence on the numerous factors that can act by modifying the profile of the intestinal microbiota of the infant, thereby promoting or inhibiting the risk of asthma later in life. The following factors are specifically addressed in depth here: diet during pregnancy, maternal adherence to a Mediterranean diet, mode of delivery, exposure to antibiotics, and type of infant feeding during the first three months of life.

Indexed as

asthmagut–lung axisgut microbiota

Identifiers

PMID39065238
PMCPMC11278858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.